RubyFMeredithMDFASTRO
Radiation Oncology • Birmingham, ALProfessor of Radiation Oncology, University Alabama
Dr. Meredith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
619 19th St S
Birmingham, AL 35249Phone+1 205-934-5670Fax+1 205-975-7039
Summary
- Research Director
Education & Training
Ohio State University College of MedicineClass of 1983
OtherClass of 1983
Certifications & Licensure
AL State Medical License 1987 - 2024
VA State Medical License 1984 - 2016- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014, 2020
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer Start of enrollment: 1996 Mar 01
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer Start of enrollment: 2001 Oct 01
- Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002) Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 171 citationsDosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.Jimmy J. Caudell, Philip E. Schaner, Renee A. Desmond, Ruby F. Meredith, Sharon A. Spencer
International Journal of Radiation Oncology, Biology, Physics. 2010-02-01 - 230 citationsFactors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancerJimmy J. Caudell, Philip E. Schaner, Ruby F. Meredith, Julie L. Locher, Lisle Nabell
International Journal of Radiation Oncology, Biology, Physics. 2009-02-01 - 93 citationsTreatment of Metastatic Prostate Carcinoma with Radiolabeled Antibody CC49.Ruby F. Meredith, Anton J. Bueschen, M. B. Khazaeli, Plott We, William E. Grizzle
Journal of Nuclear Medicine. 1994-06-01
Grant Support
- 90y-Zevalin Radioimmunotherapy Using A Modified Treatment Regimen For Relapsed ONational Center For Research Resources2007
- C225 With Chemoradiation For Post-Op Head And Neck Squamous Cell CancerNational Center For Research Resources2006–2007
- UAB 9846 Phase I Trial Of 131i-Hucc49dch2 For Colon CancerNational Center For Research Resources2005–2006
- C225 With Chemoradiation For NsclcNational Center For Research Resources2005–2006
- Pretargeting Radioimmunotherapy Of Metastatic BreastNational Cancer Institute2000–2002
- Recombinant Keratinocyte Growth Factor In Head &Neck CancerNational Center For Research Resources1999–2002
- Interferon Enhanced CC49 Monoclonal Antibody In Metastatic Prostate CancerNational Center For Research Resources1996–1997
- Intraperitoneal Radioimmunochemotherapy Of CancerNational Cancer Institute1995
External Links
- UAB Radiation Oncologyhttp://www.uab.edu/medicine/radonc
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
